Dimensional Fund Advisors’s Aptose Biosciences APTO Stock Holding History
Bought
Maintained
Sold
Other funds holding APTO
Dimensional Fund Advisors's APTO Position: Q4 2022 in Review
Dimensional Fund Advisors sold out of Aptose Biosciences (APTO) in Q4 2022, closing a stake of 152 shares — an estimated $41K sold.
Dimensional Fund Advisors first reported a position in APTO in Q3 2021 and held it in 5 quarters. The position peaked at $149K in Q3 2021. 46 funds tracked by Wall St. Rank hold APTO as of Q4 2022.
- Dimensional Fund Advisors reported no remaining Aptose Biosciences position as of Q4 2022 after selling out during the quarter.
- Dimensional Fund Advisors sold 152 Aptose Biosciences shares in Q4 2022, an estimated $41K.
- Dimensional Fund Advisors first reported a position in Aptose Biosciences in Q3 2021 and held it in 5 quarters.
- Dimensional Fund Advisors's Aptose Biosciences position peaked at $149K in Q3 2021.
- 46 funds tracked by Wall St. Rank held Aptose Biosciences as of Q4 2022.
Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.